Abstract
We demonstrated recently that cytochrome b5 plays an important in vivo role in hepatic cytochrome P450 (P450) function [J Biol Chem 283:31385–31393, 2008]. We have now generated a model in which cytochrome b5 has been deleted in all tissues [cytochrome b5 complete null (BCN)], which surprisingly results in a viable mouse despite the putative in vivo roles of this protein in lipid and steroid hormone metabolism and the reduction of methemoglobin. In contrast to the liver-specific deletion, complete deletion of cytochrome b5 leads to a neonatal increase in the expression of many hepatic P450s at both the protein and mRNA level. In extrahepatic tissues, some changes in P450 expression were also observed that were isoform-dependent. In vitro cytochrome P450 activities in liver, kidney, lung, and small intestine of BCN mice were determined for a range of model substrates and probe drugs; a profound reduction in the metabolism of some substrates, particularly in lung, kidney, and small intestine, was observed. In vivo, the metabolism of metoprolol was significantly altered in BCN mice, in contrast to the previous finding in the liver-specific cytochrome b5 deletion, suggesting that extrahepatic cytochrome b5 plays a significant role in its disposition. Testicular Cyp17 hydroxylase and lyase activities were also significantly reduced by cytochrome b5 deletion, leading to significantly lower levels of testicular testosterone. The BCN mouse provides an additional model system with which to further investigate the functions of cytochrome b5, particularly in extrahepatic tissues.
Footnotes
-
This work was supported by the Cancer Research UK Programme [Grant C4639/A5661].
-
Article, publication date, and citation information can be found at http://molpharm.aspetjournals.org.
doi:10.1124/mol.110.064246.
-
ABBREVIATIONS:
- P450
- cytochrome P450
- BCN
- cytochrome b5 complete knockout mice, Cytb 5(−/−)
- BFC
- 7-benzyloxy-4-trifluoromethylcoumarin
- BR
- benzyloxyresorufin
- EFC
- 7-ethoxy-4-trifluoromethylcoumarin
- ER
- ethoxyresorufin
- HPLC
- high-performance liquid chromatography
- LC/MS-MS
- liquid chromatography/tandem mass spectrometry
- MFC
- 7-methoxy-4-trifluoromethylcoumarin
- MR
- methoxyresorufin
- POR
- cytochrome P450 oxidoreductase
- PR
- pentoxyresorufin
- WT
- wild type, Cytb5(+/+)
- PCR
- polymerase chain reaction.
- Received February 17, 2010.
- Accepted April 29, 2010.
- Copyright © 2010 The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|